Ebiquity Plc (EBQ)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 9.000 |
|---|---|
| 52-week range | 8.620 – 15.000 |
| Return, 1 month / 3 months | −7.7% / −4.0% |
| Return, 1 year / 3 years | −37.9% / −74.6% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 17.6% |
| Worst drawdown (1 year) | -40.3% |
| Average daily value traded | 1.02M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Ebiquity is a marketing and media analytics consultancy based in London. It advises advertisers and brands on how their marketing and media spending performs, offering services such as media auditing, marketing effectiveness measurement, and analysis of advertising and media agency arrangements. Its clients are mainly large advertisers and brand owners who want independent evidence on the value and performance of their marketing investments across different media channels and markets.
Ebiquity Plc trades under the code EBQ on the London Stock Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ebiquity Plc (EBQ) trades on the London Stock Exchange in UK. It last closed at GBX 9.000 on 27 October 2026.
Its price-based Market X-Ray is 37 out of 100 (a weak price profile), ranking 2,767 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 37.9% and over the last three months it fell 4.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -17.7% | ||
| From 52-week high | -37.9% | ||
| Momentum | 24 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -4.0% | ||
| 6-month return | -21.1% | ||
| 12-month return, skipping the last month | -32.8% | ||
| Stability (higher is calmer) | 61 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 17.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.3% | ||
| Liquidity | 53 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.02M GBX | ||
| Zero-volume days | 8.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.3% |
|---|---|
| 1 month | −7.7% |
| 3 months | −4.0% |
| 6 months | −21.1% |
| 1 year | −37.9% |
| 3 years | −74.6% |
| 5 years | −83.5% |
Signals
| 50-day / 200-day average | 9.507 / 10.929 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.266 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 May 2019 | GBP 0.0071 |
| 29 May 2019 | GBP 0.5291 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.